[
  {
    "question": "A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/\u03bcL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis?",
    "answer": "Based on the clinical presentation, profound immunosuppression (CD4 count 90/\u03bcL), solitary ring-enhancing brain lesion, and positive Epstein-Barr virus (EBV) DNA in the cerebrospinal fluid, the most likely diagnosis is Primary CNS Lymphoma (PCNSL). PCNSL is strongly associated with EBV in immunocompromised individuals, particularly those with advanced HIV infection.",
    "true_answer": "The most likely diagnosis for a patient with HIV, presenting with neurological symptoms and a solitary ring-enhancing lesion, is primary cerebral lymphoma."
  },
  {
    "question": "A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein?",
    "answer": "The medication that acts on the gp41 subunit of the HIV envelope glycoprotein is Enfuvirtide (Fuzeon). It is a fusion inhibitor that prevents HIV from entering the host cell.",
    "true_answer": "The medication that targets the gp41 subunit of the HIV envelope glycoprotein is enfuvirtide."
  },
  {
    "question": "A 27-year-old man presents with a 2-week history of fever, malaise, and occasional diarrhea. On physical examination, the physician notes enlarged inguinal lymph nodes. An HIV-1 detection test is positive. Laboratory studies show a CD4+ count of 650/mm3. This patient is most likely currently in what stage of HIV infection?",
    "answer": "Based on the acute onset of symptoms (fever, malaise, diarrhea) and enlarged lymph nodes, consistent with acute retroviral syndrome, shortly after acquiring HIV, this patient is most likely currently in the **acute stage** of HIV infection. The CD4 count of 650/mm3 is within the range that can be seen during acute or early chronic infection.",
    "true_answer": "This patient is most likely currently in the stage of acute HIV infection."
  },
  {
    "question": "A 50-year-old male with HIV presents to his primary care provider complaining of persistent fevers and night sweats over the past four months. He has also experienced a productive cough. He has been poorly adherent to his HAART regimen. His past medical history also includes gout, hypertension, and diabetes mellitus. He takes allopurinol, enalapril, and metformin. His temperature is 100.9\u00b0F (38.3\u00b0C), blood pressure is 125/75 mmHg, pulse is 95/min, and respirations are 20/min. His CD4 count is 85 cell/mm^3 and a PPD is negative. A chest radiograph reveals cavitations in the left upper lobe and left lower lobe. Bronchoalveolar lavage reveals the presence of partially acid-fast gram-positive branching rods. A head CT is negative for any intracranial process. What is the mechanism of action of the most appropriate drug for managing this patient\u2019s condition?",
    "answer": "Based on the clinical presentation, lab findings (low CD4 count, cavitary lesions), and microscopy (partially acid-fast gram-positive branching rods), the likely diagnosis is pulmonary nocardiosis.\n\nThe most appropriate initial drug for managing nocardiosis is typically trimethoprim-sulfamethoxazole (TMP-SMX).\n\nIts mechanism of action involves inhibiting the bacterial synthesis of tetrahydrofolic acid:\n*   Sulfamethoxazole inhibits dihydropteroate synthase.\n*   Trimethoprim inhibits dihydrofolate reductase.",
    "true_answer": "The mechanism of action of the most appropriate drug to manage this patient's condition is inhibition of bacterial folic acid synthesis."
  },
  {
    "question": "A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing?",
    "answer": "Based on your description, the most likely target of the antibody the physician scientist is designing is **gp120**.\n\nThis is because gp120 is the outer surface glycoprotein of the HIV envelope. It is the protein responsible for binding to CD4 receptors and co-receptors on host cells, a critical step for viral entry. Neutralizing antibodies primarily target gp120 or the gp120/gp41 interface to block this process. Natural antibodies detected in diagnostic tests also target gp120 and its precursor gp160, as well as gp41. However, gp120 is generally considered a primary target for potent neutralizing antibodies.",
    "true_answer": "The most likely target of the antibody being designed for HIV envelope proteins is gp120."
  },
  {
    "question": "A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism?",
    "answer": "Based on the biopsy finding of septate hyphae branching at acute angles in the context of a cavitary pulmonary lesion in an HIV-positive patient, the most likely causal organism is *Aspergillus* species.",
    "true_answer": "The most likely causal organism for the symptoms presented is Aspergillus fumigatus."
  },
  {
    "question": "A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3\u20134 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?",
    "answer": "Adding valganciclovir to this patient's regimen, particularly with concurrent zidovudine, significantly increases the risk of **myelosuppression**.\n\nSpecifically, the greatest risk is for **anemia** and **neutropenia** due to the additive toxicities of valganciclovir and zidovudine on bone marrow.",
    "true_answer": "Treatment with valganciclovir places the patient at increased risk for pancytopenia."
  },
  {
    "question": "A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient\u2019s concern?",
    "answer": "Thank you for asking this important question. It's crucial to manage the mother's anxiety and ensure appropriate testing for the infant.\n\nFor a baby born to an HIV-positive mother, testing for HIV antibodies (like the initial screening test the mother had) is *not* useful for diagnosing infection in the infant. This is because maternal HIV antibodies cross the placenta and will be present in the baby's blood for several months, even if the baby is not infected.\n\nThe most appropriate diagnostic test for HIV infection in a newborn or infant exposed to HIV *in utero* or during birth is a **virologic test**. This test detects the presence of the virus itself or its genetic material, rather than antibodies.\n\nExamples of virologic tests include:\n\n*   **HIV DNA Polymerase Chain Reaction (PCR)**\n*   **HIV RNA Polymerase Chain Reaction (PCR)**\n\nThese tests are highly sensitive and can detect HIV infection in infants much earlier than antibody tests. Multiple virologic tests are typically performed over the first few months of life according to established guidelines to definitively determine the infant's HIV status. The first test is often performed relatively early after birth (e.g., within 14-48 hours).",
    "true_answer": "The most appropriate test for early HIV diagnosis in a newborn is the polymerase chain reaction (PCR) for HIV RNA."
  },
  {
    "question": "A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?",
    "answer": "The most appropriate next step is for the physician to strongly counsel the patient on the importance of disclosing his HIV status to his wife due to the significant health risks to her. The physician should emphasize the medical necessity for her to be tested and take precautions.\n\nThe physician should:\n1.  Explain the transmission risks and the serious implications for the wife's health.\n2.  Strongly encourage the patient to inform his wife himself, offering support or resources for how to have this conversation.\n3.  Explain the mandatory public health reporting requirements for HIV (which typically do not involve the physician directly notifying the partner, but may involve public health partner notification services depending on state law and patient cooperation).\n4.  Inform the patient that while physician-patient confidentiality is paramount, the situation involves a potential harm to a third party (who is also the physician's patient), and this creates complex ethical and potential legal considerations depending on state law regarding duty to warn/protect or partner notification. However, the immediate priority is facilitating patient-led disclosure.\n\nDirectly disclosing the diagnosis to the wife *without* the patient's consent is a breach of confidentiality and generally not permissible under HIPAA, although specific state laws regarding communicable diseases and a physician's duty to warn may apply and can vary. Attempting to get the patient to disclose himself, often with the support of public health resources, is the standard first approach.",
    "true_answer": "The physician should report the HIV infection to the national health authorities while maintaining confidentiality per regulations."
  },
  {
    "question": "A 41-year-old woman presents with acute onset severe epigastric pain radiating to the back that began a few hours ago. She also complains of nausea and has vomited twice in the past hour. She denies any history of similar symptoms or trauma in the past. Past medical history is significant for diabetes type 2 and HIV infection diagnosed 6 months ago long-standing mild intermittent asthma, and generalized anxiety disorder. She takes metformin for her diabetes but does not remember the names of her HIV medications. She reports moderate social alcohol use. Her vital signs include temperature 37.6\u00b0C (99.6 \u00b0F), pulse 95/min, blood pressure 110/74 mm Hg, respiratory rate 12/min Her body mass index (BMI) is 21 kg/m2. Laboratory findings are significant for the following: Serum amylase: 415 U/L, Serum lipase: 520 U/L. A contrast CT of the abdomen reveals an edematous pancreas with peripancreatic fluid collection with a normal gallbladder. What is the most likely etiology of this patient\u2019s condition?",
    "answer": "Based on the clinical presentation, laboratory findings, and imaging, the patient has acute pancreatitis. Given her history of HIV infection and current use of antiretroviral therapy (ART) \u2013 even though the specific drugs are not known \u2013 **drug-induced pancreatitis, likely due to her HIV medications (ART)**, is the most probable etiology.\n\nWhile moderate alcohol use is mentioned, it's less strongly associated with acute pancreatitis than certain ARVs. Gallstones are effectively ruled out by the CT scan. Other causes like severe hypertriglyceridemia or specific infections would require further investigation. However, in a patient on ART presenting with acute pancreatitis, drug-induced cause is high on the differential.",
    "true_answer": "It is most likely related to their HIV medication."
  },
  {
    "question": " A 28-year-old primigravid woman at 38 weeks' gestation is brought to the emergency department in active labor. She has not had regular prenatal care. She has a history of HIV infection but is not currently on antiretroviral therapy. Her previous viral load is unknown. Treatment with intravenous zidovudine is begun to reduce perinatal transmission of the virus. What biological process is most likely disrupted by this drug\u2019s action mechanism?",
    "answer": "Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI). It is metabolized intracellularly to its active triphosphate form, which competes with natural thymidine triphosphate and is incorporated into the viral DNA chain by HIV reverse transcriptase. This incorporation causes premature chain termination because the drug lacks a 3'-hydroxyl group.\n\nTherefore, the biological process most likely disrupted is **reverse transcription**, the process by which HIV's RNA genome is converted into DNA by the viral enzyme reverse transcriptase. This step is essential for HIV replication.",
    "true_answer": " Zidovudine affects elongation of viral DNA by inhibiting the viral reverse transcriptase enzyme."
  },
  {
    "question": "What is known about DNA methylation profiles in patients with latent HIV-1 or with an active infection?",
    "answer": "Yes, DNA methylation profiles are different in cells from individuals with HIV, and specific patterns are associated with both latency and active infection.\n\n1.  **Latent HIV-1:** DNA methylation plays a crucial role in maintaining HIV latency. Specifically, methylation patterns around the integrated proviral DNA (especially in the 5' LTR region) are associated with transcriptional silencing of the virus, helping to keep it in a latent state.\n2.  **Active/Chronic HIV-1 Infection:** In cells from individuals with active or chronic HIV infection (even those on suppressive ART), there are broader changes in DNA methylation patterns across the host genome compared to individuals without HIV. These changes are thought to be linked to chronic inflammation, immune activation, and potentially the presence of the virus itself or the effects of antiretroviral therapy. These global changes differ from the specific patterns involved in maintaining proviral latency.\n\nSo, methylation is involved in the mechanism of latency *at the provirus*, and there are also wider methylation changes in host cells during active/chronic infection.",
    "true_answer": "DNA methylation is correlated with and functionally linked to HIV-1 pathogenesis and latency. In active infection, HIV-1 infection is associated with global changes in host cell DNA methylation patterns, while in latent infection, methylation of the proviral DNA, particularly in the 5\u2019 LTR promoter and intragenic regions, plays a crucial role in maintaining viral latency."
  }
]